U-Chart Analysis:Astellas Pharma Inc.:4503

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Astellas Pharma Inc. Go to web site 4503 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Astellas Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Balance Sheet 2025年3月期 Astellas Pharma Inc. Balance Sheet 2024年3月期 Astellas Pharma Inc. Balance Sheet 2023年3月期 Astellas Pharma Inc. Balance Sheet 2022年3月期 Astellas Pharma Inc. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 188,372 335,687 376,840 315,986 326,128
Other Current AssetsHelp 1,012,977 859,043 673,114 607,368 546,460
Tangible Fixed AssetsHelp 328,921 293,742 286,459 269,044 264,623
Intangible Fixed AssetHelp 1,123,714 1,453,824 562,496 623,431 651,427
Investments and OthersHelp 270,353 208,613 229,198 213,536 200,979
Total AssetsHelp 3,339,544 3,569,603 2,456,518 2,332,395 2,273,628
Total Current LiabilitiesHelp 1,261,396 1,525,877 808,640 776,201 688,492
Total Long-term LiabilitiesHelp 564,893 447,738 139,924 95,886 199,021
Shareholder's EquityHelp 1,513,255 1,595,988 1,507,954 1,460,308 1,386,115
Total LiabilitiesHelp 3,339,544 3,569,603 2,456,518 2,332,395 2,273,628

Astellas Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Profit and Loss Account 2025年3月期 Astellas Pharma Inc. Profit and Loss Account 2024年3月期 Astellas Pharma Inc. Profit and Loss Account 2023年3月期 Astellas Pharma Inc. Profit and Loss Account 2022年3月期 Astellas Pharma Inc. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 1,912,323 1,603,672 1,518,619 1,296,163 1,249,528
Total Sales 1,912,323 1,603,672 1,518,619 1,296,163 1,249,528
Cost of SalesHelp 349,206 292,485 288,353 253,009 246,063
Other Costs and RevenueHelp 1,512,370 1,294,142 1,131,552 919,068 882,875
Total CostsHelp 1,861,576 1,586,627 1,419,905 1,172,077 1,128,938
Net RevenueHelp 1,563,117 1,311,187 1,230,266 1,043,154 1,003,465
Earnings Before TaxHelp 31,237 24,969 132,361 156,886 145,324
Net IncomeHelp 50,747 17,045 98,714 124,086 120,590
Net Income 50,747 17,045 98,714 124,086 120,590

Astellas Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Cash Flow Statement 2025年3月期 Astellas Pharma Inc. Cash Flow Statement 2024年3月期 Astellas Pharma Inc. Cash Flow Statement 2023年3月期 Astellas Pharma Inc. Cash Flow Statement 2022年3月期 Astellas Pharma Inc. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 194,511 172,476 327,767 257,443 306,843
Investing Cash Flow(ICF)Help -89,419 -845,802 -84,500 -62,413 -81,894
Financing Cash FlowHelp -261,367 614,060 -195,623 -216,298 -229,479
Exchange Difference of Cash and Cash EquivalentsHelp 8,960 18,113 13,210 11,125 12,267
Net Increase and Decrease in Cash and Cash Equivalentsn -147,315 -41,153 60,854 -10,143 7,737

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Astellas Pharma Inc.

Company where related level is highHelp

MEDICAL & BIOLOGICAL LABORATORIES CO.
TOWA PHARMACEUTICAL CO.,LTD.
Nichi-Iko Pharmaceutical Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.
Delta-Fly Pharma,Inc.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
NANO MRNA Co., Ltd.
Takeda Pharmaceutical Company Limited
K Pharma,Inc.
Sumitomo Pharma Co., Ltd.